Nucala and Dupixent are recommended as treatment options for asthma in guidelines from the Global Initiative for Asthma. Both drugs are also listed as treatment options for CRwNP in guidance from ...

If you have moderate to severe asthma, your lungs may have ... Your doctor will help determine the treatment plan that fits your needs. Dupixent reduces inflammation in your body, including ...

asthma, chronic rhinosinusitis with nasal polyposis (CRSwNP), prurigo nodularis and chronic spontaneous urticaria (CSU). Dupixent for the treatment of COPD has been approved in more than 45 countries ...

Dupixent approved as the first-ever biologic medicine in Japan for patients with COPDFollowing recent approvals in the EU, China, and the US, ...

They may suggest a treatment to manage your symptoms and can determine whether you should keep taking Ebglyss or Dupixent. If you have symptoms of a severe allergic reaction, such as swelling or ...

Dupixent (dupilumab) is available in Japan in a 300 mg dose as a pre-filled syringe or pre-filled pen and is now available ...

Dupixent reduces lung inflammation and can help some people with asthma reduce corticosteroid ... Dupixent as an add-on to your existing COPD treatment. How fast Dupixent starts to work depends ...

Regeneron’s Eylea franchise remains resilient despite biosimilar competition. Read what makes REGN stock a Strong Buy despite ...

asthma, chronic rhinosinusitis with nasal polyposis (CRSwNP), prurigo nodularis and chronic spontaneous urticaria (CSU). Dupixent for the treatment of COPD has been approved in more than 45 ...

Sanofi & Regeneron’s Dupixent receives Japanese marketing approval to treat patients with COPD: Paris Saturday, March 29, 2025, 09:00 Hrs [IST] The Ministry of Health, Labour an ...